A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone

Brain-derived neurotrophic factor (BDNF), a cognate ligand for the tyrosine kinase receptor B (TrkB) receptor, mediates neuronal survival, differentiation, synaptic plasticity, and neurogenesis. However, BDNF has a poor pharmacokinetic profile that limits its therapeutic potential. Here we report the identification of 7,8-dihydroxyflavone as a bioactive high-affinity TrkB agonist that provokes receptor dimerization and autophosphorylation and activation of downstream signaling. 7,8-Dihydroxyflavone protected wild-type, but not TrkB-deficient, neurons from apoptosis. Administration of 7,8-dihydroxyflavone to mice activated TrkB in the brain, inhibited kainic acid-induced toxicity, decreased infarct volumes in stroke in a TrkB-dependent manner, and was neuroprotective in an animal model of Parkinson disease. Thus, 7,8-dihydroxyflavone imitates BDNF and acts as a robust TrkB agonist, providing a powerful therapeutic tool for the treatment of various neurological diseases.

[1]  M. Vukovich,et al.  Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. , 1999, JAMA.

[2]  K. Vafeiadou,et al.  Activation of pro‐survival Akt and ERK1/2 signalling pathways underlie the anti‐apoptotic effects of flavanones in cortical neurons , 2007, Journal of neurochemistry.

[3]  B. Vallee,et al.  Daidzin inhibits mitochondrial aldehyde dehydrogenase and suppresses ethanol intake of Syrian golden hamsters. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  F. Hefti.  Neurotrophic factor therapy for nervous system degenerative diseases. , 1994, Journal of neurobiology.

[5]  E. Ekestern.  Neurotrophic Factors and Amyotrophic Lateral Sclerosis , 2004, Neurodegenerative Diseases.

[6]  R. Penn,et al.  A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[7]  H. Thoenen,et al.  Brain‐derived Neurotrophic Factor is a Survival Factor for Cultured Rat Cerebellar Granule Neurons and Protects them Against Glutamate‐induced Neurotoxicity , 1993, The European journal of neuroscience.

[8]  J. Kellis,et al.  Inhibition of human estrogen synthetase (aromatase) by flavones. , 1984, Science.

[9]  C. Williams,et al.  Advances in Flavonoid Research Since 1992 , 2001 .

[10]  Michael Sendtner,et al.  Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches , 2002, Nature Neuroscience.

[11]  D. Stein,et al.  Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death , 2007, Proceedings of the National Academy of Sciences.

[12]  D. Kaplan,et al.  High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor , 1991, Nature.

[13]  G. Siegel,et al.  Neurotrophic factors in Alzheimer’s and Parkinson’s disease brain , 2000, Brain Research Reviews.

[14]  David R Kaplan,et al.  Neurotrophin signal transduction in the nervous system , 2000, Current Opinion in Neurobiology.

[15]  Xi Chen,et al.  A Chemical-Genetic Approach to Studying Neurotrophin Signaling , 2005, Neuron.

[16]  B. Hempstead,et al.  TrkA Immunoglobulin-Like Ligand Binding Domains Inhibit Spontaneous Activation of the Receptor , 2000, Molecular and Cellular Biology.

[17]  Markus Schwaninger,et al.  Intravenous Brain-Derived Neurotrophic Factor Reduces Infarct Size and Counterregulates Bax and Bcl-2 Expression After Temporary Focal Cerebral Ischemia , 2000, Stroke.

[18]  K. Abe,et al.  Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory , 2006, Proceedings of the National Academy of Sciences.

[19]  H. Guo,et al.  Caspase-1 activation of caspase-6 in human apoptotic neurons , 2006, Cell Death and Differentiation.

[20]  Jordan M. Fletcher,et al.  Novel monocyclic and bicyclic loop mimetics of brain‐derived neurotrophic factor , 2006, Journal of peptide science : an official publication of the European Peptide Society.

[21]  R. Waring,et al.  Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment. , 2004, The Journal of clinical endocrinology and metabolism.

[22]  A. Welcher,et al.  Interactions between Brain-derived Neurotrophic Factor and the TRKB Receptor , 1997, The Journal of Biological Chemistry.

[23]  J. Harborne,et al.  Advances in flavonoid research since 1992. , 2000, Phytochemistry.

[24]  R. Hughes,et al.  Design of Potent Peptide Mimetics of Brain-derived Neurotrophic Factor* , 2003, Journal of Biological Chemistry.

[25]  N. Saarinen,et al.  No evidence for the in vivo activity of aromatase-inhibiting flavonoids , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  L. Brennan,et al.  Effects of homocysteine on metabolic pathways in cultured astrocytes , 2008, Neurochemistry International.